Zygoma, which is located at the middle third of the face, has a significant impact on the facial impression with its volume and prominence. CaO-SiO 2 -P 2 O 5 -B 2 O 3 glass-ceramics (BGS-7) has been reported as a new alternative of nonresorbable bone grafting material, which has bioactivity of inducing human osteoblast between bone and implant, resulting integration to the bone. Furthermore, its chemical characteristics are similar to bone, resulting in radiopacity with no metallic artifact on the radiographic images. With the development of Computer aided design-Computer aided manufacturing technology, BGS-7 can be manufactured into a patient-specific design.During follow-up periods, 3D printed BGS-7 implant did not displace from the initial recipient site. By cone-beam computed tomography evaluation, a gap between bone and BGS-7 was filled with the radiopacity, which implied bony fusion. Consequently, this clinical case shows that the BGS-7 implant could be an effective and safe graft material for zygoma bone defects.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1097/SCS.0000000000008527 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Comparison of Outcomes After Anterior Cervical Discectomy and Fusion Using Bioactive Glass-Ceramic Spacer-7 (NOVOMAX-FUSION) and an Allograft Spacer: A Retrospective, Case-Matched, Multicenter Study.
J Biomed Mater Res B Appl Biomater
January 2025
Department of Neurosurgery, Spine and Spinal Cord Institute, Gangnam Severance Spine Hospital, Seoul, Republic of Korea.
The bioactive glass-ceramic spacer (BGS)-7, a biosynthetic intervertebral fusion material introduced in 2014, has not been the subject of comparative clinical studies on anterior cervical discectomy and fusion (ACDF) surgery. This study, for the first time, aims to compare the radiological and clinical outcomes of the renewed BGS-7, released in 2019, with those of an allograft spacer. The comparison includes a finite element analysis of the biomechanical properties of each implant, adding a novel dimension to the research.
View Article and Find Full Text PDFBiocompatibility and dimensional stability through the use of 3D-printed scaffolds made by polycaprolactone and bioglass-7: An in vitro and in vivo study.
Clin Implant Dent Relat Res
December 2024
Department of Oral & Maxillofacial Surgery, Chung-Ang University College of Medicine, Seoul, Korea.
Purpose: This experiment aimed to observe the differences in biological properties by producing BGS-7 + PCL scaffolds with different weight fractions of BGS-7 through 3D printing and to confirm whether using the scaffold for vertical bone augmentation is effective.
Materials And Methods: Cube-shaped bioglass (BGS-7) and polycaprolactone (PCL) scaffolds with different weight fractions (PCL alone, PCL with 15% and 30% BGS-7) are produced using 3D printing. The surface hydroxyapatite (HA) apposition, the pH change, proliferation and attachment assays, and various gene expression levels are assessed.
Long-term results comparison after anterior cervical discectomy with BGS-7 spacer (NOVOMAX®-C) and allograft spacer: A prospective observational study.
Front Bioeng Biotechnol
April 2023
Gangnam Severance Hospital, Seoul, Seoul, Republic of Korea.
In an anterior cervical discectomy and fusion (ACDF), various types of graft materials including autograft, allograft, and synthetic graft have been used to achieve adequate spinal fusion. Allograft spacer is mainly used in cervical fusion, especially in the anterior approach. The synthetic bone graft material BGS-7(CaO-SiO2-P2O5-B2O3, bioactive Glass-Ceramics) can bind with surrounding bone tissue by forming a hydroxyapatite layer bone bridge, leading to faster graft osseointegration.
View Article and Find Full Text PDFComplications arising from clinical application of composite polycaprolactone/bioactive glass ceramic implants for craniofacial reconstruction: A prospective study.
J Craniomaxillofac Surg
December 2022
Department of Plastic and Reconstructive Surgery, Ulsan University College of Medicine, Asan Medical Center, Seoul, South Korea. Electronic address:
This study aimed to demonstrate the in vitro performance of a novel polymer-ceramic composite incorporating polycaprolactone (PCL) and bioactive glass (BGS-7), and investigate its clinical outcomes in craniofacial reconstruction. After preparation of the material, the biochemical properties of the composite PCL/BGS-7 implant were tested to evaluate apatite formation in simulated body fluid (SBF). Changes in the implant surface after soaking in the SBF were determined using field-emission scanning electron microscopy.
View Article and Find Full Text PDFZygoma Augmentation With 3D Printed Bioactive Glass-Ceramic Implant.
J Craniofac Surg
September 2022
Department of Oral and Maxillofacial Surgery, Dental Center, Chung-Ang University Hospital; and.
Zygoma, which is located at the middle third of the face, has a significant impact on the facial impression with its volume and prominence. CaO-SiO 2 -P 2 O 5 -B 2 O 3 glass-ceramics (BGS-7) has been reported as a new alternative of nonresorbable bone grafting material, which has bioactivity of inducing human osteoblast between bone and implant, resulting integration to the bone. Furthermore, its chemical characteristics are similar to bone, resulting in radiopacity with no metallic artifact on the radiographic images.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!